Creatine and Kidney Health — Is Supplementation Safe?

Creatine is one of the most extensively studied supplements in the world — we covered this in more depth in our knowledge-base entry on creatine — yet one particularly stubborn myth still circulates: that regular creatine intake “strains” or even “destroys” the kidneys. This belief is widespread enough that the question of creatine's kidney safety comes up in nearly every conversation about starting supplementation — sometimes raised by the person considering it, and sometimes, more curiously, by a family doctor unfamiliar with this specific biochemical nuance.

This myth doesn't come from nowhere. It has its roots in a real, measurable laboratory phenomenon — just one that gets misinterpreted. This article explains exactly what that phenomenon is, what the newest meta-analysis dedicated to this exact question found in 2025, and — most importantly — how to tell an innocuous metabolic effect apart from an actual warning sign about kidney function.

Creatine and creatinine are two different substances, even though only their endings tell them apart — and that similarity in names is part of the problem. Creatine is stored in muscle as phosphocreatine and used for rapid ATP resynthesis during exercise. Creatinine, on the other hand, is a byproduct of that process — it forms non-enzymatically when phosphocreatine and creatine in muscle undergo slow, spontaneous breakdown. In other words: creatinine is a natural metabolic “waste product” of creatine, not a toxic side effect of it.

Creatinine happens to be one of the most commonly measured parameters in routine blood work, because its blood level is a standard marker used to estimate kidney function — kidneys filter creatinine out of the blood at a relatively constant rate for a given person, so an elevated level usually suggests worse filtration. The problem is that the amount of creatinine in the blood depends not only on how well the kidneys work, but also on how much creatinine is being produced in the first place — and creatine supplementation increases the pool of substrate from which creatinine forms. More creatine in the muscles means more creatinine as a natural byproduct of its turnover, completely independent of whether the kidneys are working better, worse, or exactly the same as before.

Until now, individual smaller studies suggested the same pattern, but it's this fresh meta-analysis, dedicated specifically to this question, that lets us look at the phenomenon in aggregate, across a larger combined sample.

The meta-analysis authors interpret this result in line with the mechanism described in the previous section: the small rise in creatinine most likely reflects increased metabolic turnover of creatine — meaning more substrate being converted into creatinine — rather than an actual decline in kidney function. If supplementation genuinely impaired renal filtration, we would expect a parallel drop in GFR. That didn't happen — GFR remained stable despite the measurable rise in creatinine.

This mechanism is exactly what explains why the creatine-and-kidneys myth is so persistent. Someone taking creatine gets a routine blood test, sees creatinine slightly above the lab's reference range and — without context — concludes something is wrong with their kidneys. Sometimes a doctor unfamiliar with this specific nuance makes the same mistake, especially if the patient doesn't mention creatine supplementation during the visit. In both cases, a single elevated creatinine result leads to unnecessary worry, and sometimes to advice to stop the supplement, even though actual kidney function — as measured by GFR — remains unchanged.

There's also a limitation in the meta-analysis itself: a combined sample of 177 people taking creatine across 12 studies is solid for this type of systematic review, but still relatively small in absolute terms. The individual studies also varied in duration and dosing protocols, which limits confidence about the effects of very long-term supplementation (many years) compared with the timeframes of weeks to a few months that dominated the studies analyzed.

The creatine-and-kidneys myth is a good example of how easily a single lab result, taken out of context, can cement a false belief for years — even among people who work with blood test results every day. The 2025 meta-analysis isn't the first voice on this, but it's one of the most precise: it clearly separates what actually rises (creatinine, slightly) from what should actually matter to us (kidney filtration function, measured by GFR, which stays stable).

At the same time, being honest with the data requires a clear caveat: this is evidence of safety for healthy people, not a universal guarantee for everyone. Anyone who has had, or is currently treating, any kidney disease should make this decision together with a doctor — not based on an article on the internet, including this one.